These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20203443)

  • 1. [Gemcitabine therapy for unresectable pancreatic cancer in elderly patients].
    Katakura Y; Nakahara K; Kobayashi M; Adachi S; Izawa N; Noguchi Y; Nakatsu S; Sato Y; Takagi R; Itoh F
    Nihon Shokakibyo Gakkai Zasshi; 2010 Mar; 107(3):396-406. PubMed ID: 20203443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-dose gemcitabine on unresectable pancreatic cancer in elderly patients.
    Matsumoto K; Miyake Y; Kato H; Kawamoto H; Imagawa A; Toyokawa T; Nakatsu M; Ando M; Hirohata M; Yamamoto K
    Digestion; 2011; 84(3):230-5. PubMed ID: 21860243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine as first-line chemotherapy in elderly patients with unresectable pancreatic carcinoma.
    Yamagishi Y; Higuchi H; Izumiya M; Sakai G; Iizuka H; Nakamura S; Adachi M; Hozawa S; Takaishi H; Hibi T
    J Gastroenterol; 2010 Nov; 45(11):1146-54. PubMed ID: 20549255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine.
    Nakai Y; Isayama H; Kawabe T; Tsujino T; Yoshida H; Sasaki T; Tada M; Arizumi T; Yagioka H; Kogure H; Togawa O; Ito Y; Matsubara S; Hirano K; Sasahira N; Omata M
    Pancreas; 2008 Nov; 37(4):405-10. PubMed ID: 18953253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of S100A4 mRNA in EUS-FNA specimens for the assessment of chemosensitivity to gemcitabine from patients with unresectable pancreatic cancer.
    Ma G; Sun Y; Fu S
    Int J Clin Exp Pathol; 2015; 8(10):13284-8. PubMed ID: 26722531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine and S-1 combination chemotherapy versus gemcitabine alone for locally advanced and metastatic pancreatic cancer: a meta-analysis of randomized controlled trials in Asia.
    Li Y; Sun J; Jiang Z; Zhang L; Liu G
    J Chemother; 2015 Aug; 27(4):227-34. PubMed ID: 25790948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy of gemcitabine-based chemotherapy on advanced pancreatic cancer].
    Gong JF; Zhang XD; Li J; Di LJ; Jin ML; Shen L
    Ai Zheng; 2007 Aug; 26(8):890-4. PubMed ID: 17697554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Usefulness of gemcitabine in the treatment of advanced pancreatic cancer in terms of its clinical benefits].
    Shiozawa S; Tsuchiya A; Kumazawa K; Ogawa K
    Gan To Kagaku Ryoho; 2003 Apr; 30(4):483-7. PubMed ID: 12722678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancer.
    Shimoda M; Katoh M; Kita J; Sawada T; Kubota K
    Chemotherapy; 2010; 56(6):501-6. PubMed ID: 21099223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gemcitabine in elderly patients with unresectable pancreas cancer].
    Hanada K; Hino F; Amano H; Ooe H; Hirota Y; Sasao S; Obayashi M; Kajiyama G
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2521-5. PubMed ID: 12506475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gemcitabine in elderly patients with advanced pancreatic cancer.
    Hentic O; Dreyer C; Rebours V; Zappa M; Lévy P; Raymond E; Ruszniewski P; Hammel P
    World J Gastroenterol; 2011 Aug; 17(30):3497-502. PubMed ID: 21941416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical problems in gemcitabine treatment for unresectable pancreatic cancer in the elderly--a multicentric retrospective study of 53 cases].
    Takeuchi N; Maejima S; Hasebe O; Matsuda Y; Hanazaki K; Kajikawa S; Mukawa K; Hosokawa K; Hayashi K; Hisa T; Furut K; Tajiri K; Fujimori Y; Kaneko G; Ochi Y; Shikama N; Kawa S; Miyagawa S; Miwa S; Kiyosawa K
    Gan To Kagaku Ryoho; 2004 Nov; 31(12):1987-91. PubMed ID: 15570926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemcitabine or gemcitabine plus cisplatin for in 42 patients with locally advanced or metastatic pancreatic cancer.
    Wang X; Ni Q; Jin M; Li Z; Wu Y; Zhao Y; Feng F
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):404-7. PubMed ID: 12408777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial.
    Loehrer PJ; Feng Y; Cardenes H; Wagner L; Brell JM; Cella D; Flynn P; Ramanathan RK; Crane CH; Alberts SR; Benson AB
    J Clin Oncol; 2011 Nov; 29(31):4105-12. PubMed ID: 21969502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas.
    Ammori JB; Colletti LM; Zalupski MM; Eckhauser FE; Greenson JK; Dimick J; Lawrence TS; McGinn CJ
    J Gastrointest Surg; 2003; 7(6):766-72. PubMed ID: 13129554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in tumor marker levels as a predictor of gemcitabine effect on patients with unresectable or recurrent pancreatic cancer].
    Tendo M; Nakata B; Nishino H; Inoue M; Kosaka K; Amano R; Yamada N; Hirakawa K
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):795-8. PubMed ID: 15984518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer.
    Kuriyama H; Kawana K; Taniguchi R; Jono F; Sakai E; Ohubo H; Suzuki H; Kobayashi S; Murata Y; Inamori M; Hata Y; Nahajima A
    Hepatogastroenterology; 2011; 58(106):270-4. PubMed ID: 21661380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two cases of advanced pancreatic cancer responding to gemcitabine with long survival of 2 years].
    Yajima T; Furukawa Y; Ishii Y; Hattori Y; Matsumoto N; Yamamoto M; Yamaoka Y; Fujihara M; Fujita M; Kuniki H
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):953-7. PubMed ID: 15222120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients.
    Kuroda T; Kumagi T; Yokota T; Azemoto N; Hasebe A; Seike H; Nishiyama M; Inada N; Shibata N; Miyata H; Kawamura T; Imai Y; Ueno-Toshimori A; Tanaka Y; Terao T; Imamura Y; Koizumi M; Yamanishi H; Ohno Y; Hiasa Y;
    BMC Gastroenterol; 2017 May; 17(1):66. PubMed ID: 28532457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent gemcitabine in elderly patients with unresectable biliary tract cancer.
    Kuriyama H; Kawana K; Taniguchi R; Jono F; Sakai E; Okubo H; Suzuki H; Kobayashi S; Murata Y; Inamori M; Hata Y; Nakajima A
    Hepatogastroenterology; 2011; 58(105):26-30. PubMed ID: 21510281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.